AD-104
- Generic Name
- AD-104
A Study to Assess the Safety and Pharmacokinetics of AD-104-A
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05703282
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath